Paid Clinical Trials in Ypsilanti, MI
As of July 2026, 133 paid clinical trials are recruiting in Ypsilanti, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Ypsilanti offers studies at sites including Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus for conditions such as Heart Failure, Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Ypsilanti
Trials by drug in Ypsilanti
Filter results
127 clinical trials
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Assessment of CCM in HF With Higher Ejection Fraction
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
A Study of ASP3082 in Adults With Advanced Solid Tumors
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
CCM OPEN HF Registry
Prevail Global Study
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
BoxX-NoAF Clinical Trial
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
CtDNA Based MRD Testing for NAC Monitoring in TNBC
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Family Communications After Genetic Testing
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Top Research Study Locations in Ypsilanti
Researchers run research studies in Ypsilanti, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus | Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8 | 82 |
| Huron Gastroenterology PC | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 42 |
| Michigan Heart | Hypertension, Hypertension, Essential, Hypertension, Systolic | 3 |
| Trinity Health | Atrial Fibrillation, Atrial Fibrillation, Postoperative, HR+/HER2-negative Breast Cancer | 3 |
| Trinity Health Ann Arbor Hospital | AV Block, Atrial Fibrillation, Bradycardia | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Huron Gastroenterology Associates, P.C. | Crohn's Disease, Ulcerative Colitis | 2 |
| Trinity Health Michigan Heart | Diabetes Mellitus, Type 2, Heart Failure, Metabolic Syndrome | 2 |
| Allergy & Immunology Associates of Ann Arbor | Dermatitis Atopic | 1 |
| Dawn Farm | Alcohol Use Disorder, Criminal Behavior, Health Risk Behaviors | 1 |
| Forest Health Medical Center | Lumbar Spinal Stenosis | 1 |
| Huron Gastro | Crohn's Disease, Ulcerative Colitis | 1 |
| Investigative | Solid Tumors | 1 |
| Michigan Heart, PC | Heart Failure | 1 |
| Michigan Otolaryngology Surgery Associates | Tonsillectomy | 1 |
| Mirador Therapeutics Selected Site | Crohn's Disease, Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) | 1 |
| Research | Severe Asthma | 1 |
| Respiratory Medicine Research Institute of Michigan PLC | Chronic Spontaneous Urticaria | 1 |
| Respiratory Medicine Research Institute of Michigan, PLC | Atopic Dermatitis, Eczema | 1 |
| Saint Joseph Mercy Ann Arbor | Coronary Artery Disease | 1 |
| St. Joseph Mercy Health System | Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis | 1 |
| St. Joseph Mercy Hospital - Huron Gastroenterology Associates | Colitis, Ulcerative, Crohn Disease | 1 |
| Tenax Investigational Site | Pulmonary Hypertension Associated With HFpEF | 1 |
| Trinity Ann Arbor d/b/a Michigan Heart Ann Arbor | Heart Failure | 1 |
| Trinity Health - Ann Arbor Hospital | Pulmonary Embolism | 1 |
Active & Upcoming Studies in Ypsilanti (2026)
Recruiting trials in Ypsilanti grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (81 active studies)
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
Cardiovascular (21 active studies)
Diabetes & metabolic (4 active studies)
Common conditions studied in Ypsilanti
- Heart Failure (7 active studies)
- Stage IV Lung Cancer AJCC v8 (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
Leading research sponsors in Ypsilanti
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- NRG Oncology
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Ypsilanti?
There are approximately 133 recruiting clinical trials in Ypsilanti, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Ypsilanti pay participants?
Most recruiting trials in Ypsilanti compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Ypsilanti?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Ypsilanti?
The most common conditions under active study in Ypsilanti include Heart Failure (7), Stage IV Lung Cancer AJCC v8 (7), Acute Myeloid Leukemia (6), Anatomic Stage II Breast Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Ypsilanti?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Ypsilanti on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Ypsilanti?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Ypsilanti?
Recruiting research sites in Ypsilanti include Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Huron Gastroenterology PC, Michigan Heart, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Ypsilanti right now?
The largest active categories in Ypsilanti are Cancer & tumors (81), Cardiovascular (21), Diabetes & metabolic (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.